Sunday, March 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

White House: Proposed Policy Targets Dual Use Research of Concern

by Global Biodefense Staff
February 22, 2013

OSTP today released for public review and comment a proposed policy aimed at maximizing the benefits of life sciences research while minimizing the odds that the results of such research will be misused.  The proposed policy, posted on the U.S. Department of Health and Human Services Science Safety Security (S3) Website, was crafted collaboratively by several Federal agencies and is now open for public comment for 60 days.

The proposed policy responds to concerns that some important and otherwise beneficial avenues of life science research have the potential to generate information or capacities that, in the wrong hands, could be misused for harmful purposes.   

Specifically, the newly proposed policy focuses on the very small fraction of studies with the highest risk of potential misuse, known as dual use research of concern (DURC).  For oversight purposes, DURC is defined as “Life sciences research that, based on current understanding, can be reasonably anticipated to provide knowledge, information, products or technology that could be directly misapplied to pose a significant threat with broad potential consequences to public health and safety, agricultural crops and other plants, animals, the environment, materiel or national security.”

The Federal Government has already taken a number of actions to reduce the risks posed by DURC.  Last March, the Administration initiated an internal policy that requires agencies to review research proposals that will be funded and those already funded; identify those that qualify as DURC; and ensure that acceptable risk-reducing mitigation plans are in place before the work is conducted.

The proposed “United States Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern,” released today, would complement that internal policy by establishing certain oversight responsibilities for universities and other research institutions that receive Federal funding. Specifically, such institutions would be required to review their current life sciences research involving those pathogens or toxins deemed to be the most dangerous or most amenable to misuse, and then work with the researchers and funding agencies to develop appropriate risk mitigation plans.

Together, the two policies can help the United States manage the risks of potential misuse throughout the research lifecycle—from the initial filing of a grant application to the conclusion of research and communication of results.

We are seeking comments on the proposed policy and welcome the input of researchers, institutions, consumers, security experts, and other stakeholders.

Please visit OSTP’s announcement of the proposed policy in the Federal Register for instructions on how to submit comments.

This article was originally published February 21, 2013 on the White House Office of Science and Technology Policy (OSTP) Blog. Author credit: Franca Jones, Assistant Director for Chemical and Biological Countermeasures at OSTP.

Tags: Dual Use Research of Concern (DURC)

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC